Health Tech Investors
Glasshouse Health advises health tech investors on the potential of an innovation to meet its projected clinical and commercial targets, based on insights from healthcare stakeholders. We advise on whether the vision and pitch is grounded in evidence, and we identify any resource and capability gaps within the team. We also highlight unidentified clinical risks, and suggest steps to mitigate them. We are actively engaged in various investor networks, representing start-ups as well as investors, meaning we understand the start-up perspective as well as the investor perspective.
Our Services
Scientific & Clinical Due Diligence
We know how unfamiliar the healthcare sector is to many start-ups. It risks mistakes that can delay progress, incur unnecessary costs, and delay revenue generation. To help avoid that, we evaluate start-ups’ pitches and plans, and advise on their reliability and chance of success.
Ask us about: pitch deck and plan review; clinical and scientific advisory boards; strategy facilitation.
Non-Executive Directors (NEDs)
We understand the value of governance and oversight for start-ups. Product innovation can crowd out aspects such as regulatory conformance, evidence generation, and health economics. We provide start-ups with an NED to ensure development stays on track.
Ask us about: NED identification and introductions; governance and oversight; compliance checks and audits.
Pitches & Deal Flow
We work directly with numerous health tech start-ups, and we are connected to many more via our networks. From time to time, we organise pitches by founders we regard as being or becoming investable. We also connect founders with potential investors.
Ask us about: health tech start-up pitches; founder connections; investor network.